Harmony Biosciences Holdings (HRMY) Inventory (2019 - 2026)

Harmony Biosciences Holdings has disclosed Inventory across 8 years of filings, most recently posting $5.4 million for Q1 2026.

• Inventory for Q1 2026 came in at $5.4 million, down 16.84% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.4 million (down 16.84% YoY), and the FY2025 annual result was $5.5 million, down 23.3% from the prior year.
• Inventory came in at $5.4 million for Q1 2026 at Harmony Biosciences Holdings, down from $5.5 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $7.2 million in Q4 2024 to a low of $4.1 million in Q1 2023.
• The 5-year median for Inventory is $5.4 million (2026), against an average of $5.6 million.
• Across the five-year window, Inventory surged 43.2% in 2024 and fell 23.3% in 2025, its largest moves.
• Harmony Biosciences Holdings' Inventory stood at $4.3 million in 2022, then gained by 24.81% to $5.4 million in 2023, then jumped by 34.22% to $7.2 million in 2024, then dropped by 23.3% to $5.5 million in 2025, then declined by 1.38% to $5.4 million in 2026.
• The last three Inventory figures came in at $5.4 million (Q1 2026), $5.5 million (Q4 2025), and $6.9 million (Q3 2025), per Business Quant data.